New diabetes clinical trial: A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects with Type 2 Diabetes Mellitus

Published on: January 22, 2025 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: DT2-SCT intravenous infusion; Other: Placebo
Sponsors: Global Institute of Stem Cell Therapy and Research (GIOSTAR)
Not yet recruiting
https://ift.tt/pY3Z1oP